{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:32:24Z","timestamp":1793151144651,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772890"],"award-info":[{"award-number":["2025M772890"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20251904"],"award-info":[{"award-number":["GZC20251904"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Research Foundation","doi-asserted-by":"publisher","award":["2025-zz-19"],"award-info":[{"award-number":["2025-zz-19"]}],"id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.compbiolchem.2026.109364","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:36:20Z","timestamp":1787787380000},"page":"109364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual targeting of VEGFR2 and ErbB3 by a novel quinoline derivative E5: Mechanistic insights from DFT, molecular docking and MD simulations"],"prefix":"10.1016","volume":"125","author":[{"given":"Xinyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2026.109364_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s44446-026-00072-4","article-title":"Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy","volume":"34","author":"Albassam","year":"2026","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ceb.2010.08.017","article-title":"The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis","volume":"22","author":"Albini","year":"2010","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/1078-0432.CCR-09-2308","article-title":"Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2","volume":"16","author":"Annunziata","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01692-8","article-title":"HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target","volume":"9","author":"Capone","year":"2023","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib5","article-title":"Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies","volume":"5","author":"Cervantes-Villagrana","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/1078-0432.CCR-21-2334","article-title":"FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma","volume":"28","author":"Chang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1382512","article-title":"Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an in vitro study","volume":"12","author":"Evteev","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib8","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, G.A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A.V. Marenich, J. Bloino, B.G. Janesko, R. Gomperts, B. Mennucci, H.P. Hratchian, J.V. Ortiz, A.F. Izmaylov, J.L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V.G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J.A. Montgomery, Jr., J.E. Peralta, F. Ogliaro, M.J. Bearpark, J.J. Heyd, E.N. Brothers, K.N. Kudin, V.N. Staroverov, T.A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A.P. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, J.M. Millam, M. Klene, C. Adamo, R. Cammi, J.W. Ochterski, R.L. Martin, K. Morokuma, O. Farkas, J.B. Foresman, and D.J. Fox. Gaussian 16, Revision C.01. (Version, 2023-04-17 09:43:00, 2016)."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","article-title":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","volume":"13","author":"Gotink","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.compbiolchem.2026.109364_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1078-0432.CCR-09-2353","article-title":"AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer","volume":"16","author":"Hickinson","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib12","article-title":"Overview of management and therapeutic advances in medullary thyroid cancer","volume":"5","author":"Jara","year":"2025","journal-title":"Endocrine oncology (Bristol England)"},{"key":"10.1016\/j.compbiolchem.2026.109364_bib13","doi-asserted-by":"crossref","first-page":"21608","DOI":"10.1073\/pnas.0912101106","article-title":"Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3","volume":"106","author":"Jura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109364_bib14","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa \u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations[J]","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","article-title":"Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC","volume":"16","author":"Le","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib16","first-page":"17","article-title":"Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics","author":"Liao","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.compbiolchem.2026.109364_bib17","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.3390\/nu6115184","article-title":"The Role of n-3 Polyunsaturated Fatty Acids in the Prevention and Treatment of Breast Cancer","volume":"6","author":"Liu","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.compbiolchem.2026.109364_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007790","article-title":"The thiophene \u03b1-terthienylmethanol isolated from Tagetes minuta inhibits angiogenesis by targeting protein kinase C isozymes \u03b1 and \u03b22","volume":"13","author":"Llorens de los Rios","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib20","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/theoncologist.2008-0261","article-title":"Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions","volume":"14","author":"Morabito","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.compbiolchem.2026.109364_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-026-02244-8","article-title":"Cytoplasmic LIM domain only 2 enhances tumor endothelial cell migration through integrin \u03b21-mediated focal adhesion signaling","volume":"14","author":"Park","year":"2026","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00044-024-03252-w","article-title":"Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy","volume":"33","author":"Reang","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biopha.2017.03.018","article-title":"Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection","volume":"90","author":"Ruiz-Ceja","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ccr.2009.12.047","article-title":"An Activated ErbB3\/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells","volume":"17","author":"Sheng","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70746","article-title":"Mechanisms of HIF-1\u03b1 Function in Malignant Cells and Associated Therapeutic Strategies","volume":"40","author":"Sun","year":"2026","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2004.09.026","article-title":"Loss of HIF-1\u03b1 in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis","volume":"6","author":"Tang","year":"2004","journal-title":"Cancer Cell."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib28","article-title":"Voxel-wise analysis of brain metastasis predilection sites in breast cancer by clinical features","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib30","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1039\/b508541a","article-title":"Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy","volume":"7","author":"Weigend","year":"2005","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641522","article-title":"Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma","volume":"11","author":"Zeng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib32","article-title":"Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00214-007-0310-x","volume":"120","author":"Zhao","year":"2008","journal-title":"Theor. Chem. Acc."},{"key":"10.1016\/j.compbiolchem.2026.109364_bib34","article-title":"Emerging trends and knowledge networks in pan-cancer sorafenib resistance: a 20-year bibliometric investigation","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126004913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126004913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:40:58Z","timestamp":1793148058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126004913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S1476927126004913"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109364","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of VEGFR2 and ErbB3 by a novel quinoline derivative E5: Mechanistic insights from DFT, molecular docking and MD simulations","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109364"}}